4D Molecular Therapeutics Inc
NASDAQ:FDMT

Watchlist Manager
4D Molecular Therapeutics Inc Logo
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Watchlist
Price: 10.92 USD 0.83%
Market Cap: 624m USD

Wall Street
Price Targets

FDMT Price Targets Summary
4D Molecular Therapeutics Inc

Wall Street analysts forecast FDMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FDMT is 33.77 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

Lowest
Price Target
17.17 USD
57% Upside
Average
Price Target
33.77 USD
209% Upside
Highest
Price Target
47.25 USD
333% Upside
4D Molecular Therapeutics Inc Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
12% Upside
CHRS
Coherus BioSciences Inc
272% Upside
87S
Roivant Sciences Ltd
19% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
19% Upside
301047
Sino Biological Inc
18% Upside
600201
Jinyu Bio-Technology Co Ltd
42% Downside
301207
Hualan Biological Bacterin Inc
3% Downside
SYNACT
SynAct Pharma AB
25% Upside

Revenue
Forecast

Revenue Estimate
4D Molecular Therapeutics Inc

For the last 6 years the compound annual growth rate for 4D Molecular Therapeutics Inc's revenue is -63%. The projected CAGR for the next 3 years is 738%.

-63%
Past Growth
738%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
4D Molecular Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
4D Molecular Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FDMT's stock price target?
Price Target
33.77 USD

According to Wall Street analysts, the average 1-year price target for FDMT is 33.77 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

What is 4D Molecular Therapeutics Inc's Revenue forecast?
Projected CAGR
738%

For the last 6 years the compound annual growth rate for 4D Molecular Therapeutics Inc's revenue is -63%. The projected CAGR for the next 3 years is 738%.

Back to Top